Clinical Trial Update: Effect of Imatinib on Bone Metabolism in Patients With Chronic Myelogenous Leukemia or Gastrointestinal Stromal Tumors [NA]

View source ↗

Summary

A completed clinical trial evaluating how imatinib affects bone metabolism in patients with chronic myelogenous leukemia or gastrointestinal stromal tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastrointestinal Stromal Tumor
• Myelogenous Leukemia

Drugs mentioned

• Gleevec (Imatinib)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Gastric Cancer, Leukemia | NA | Status: COMPLETED